Sort
11,323 grants matching “glioblastoma”
Molecular Mechanisms and Therapeutic Approaches to Malignant Gliomas
$651,432Tony R. Hunter · Salk Institute For Biological Studies · R01 · FY2019 · CA
EGFRwt and EGFRvlll Dual-Specific Immunotoxin for Glioblastoma Multiforme
$651,410Darell D Bigner · Duke University · P01 · FY2015 · CA
Sonobiopsy for Noninvasive Genetic Evaluation of Glioblastoma Patients
$651,157Eric Claude Leuthardt · Washington University · R01 · FY2023 · CA
Steady states and cellular transitions associated with carcinogenesis and tumorprogression
$650,589James R. Heath · Institute For Systems Biology · U01 · FY2019 · CA
Project 2: Regulation of Pre-mRNA Splicing in Tumorigenesis
$650,373Adrian R Krainer · Cold Spring Harbor Laboratory · P01 · FY2022 · CA
Metabolic Reprogramming in Brain Tumors
$650,013Sabrina Miriam Ronen · University Of California, San Francisco · R01 · FY2021 · CA
Quantitative imaging phenotypic classifier for distinguishing radiation effects from tumor recurrence in Glioblastoma
$649,730Pallavi Tiwari · University Of Wisconsin-Madison · R01 · FY2022 · CA
Organ-specific, Blood Protein Biomarkers for an Informative Diagnosis of Brain an
$649,409Leroy E Hood · California Institute Of Technology · U54 · FY2013 · CA
Metallofullerene Nanoplatform for Imaging & Treatment
$649,395Panos Peter Fatouros · Virginia Commonwealth University · R01 · FY2008 · CA
Development of the brain penetrant ATM inhibitor WSD0628 in combination with radiation for recurrent high grade glioma
$649,264Jann N Sarkaria · Mayo Clinic Rochester · R01 · FY2025 · FD
Development of the brain penetrant ATM inhibitor WSD0628 in combination with radiation for recurrent high grade glioma
$649,261Jann N Sarkaria · Mayo Clinic Rochester · R01 · FY2023 · FD
Therapeutic targeting mesenchymal transition in newly diagnosed and recurrent GBM
$649,226Frank Furnari · University Of California, San Diego · R01 · FY2024 · NS
Signal Transduction by Tyrosine Phosphorylation
$649,169Tony R. Hunter · Salk Institute For Biological Studies · R01 · FY2014 · CA
Advancing treatment outcomes in malignant glioma by integrating immunotherapy and standard of care using genetically engineered mice that recapitulate molecular feature of human glioma
$648,944Alain Charest · Beth Israel Deaconess Medical Center · R01 · FY2020 · CA
Advancing treatment outcomes in malignant glioma by integrating immunotherapy and standard of care using genetically engineered mice that recapitulate molecular feature of human glioma
$648,944Alain Charest · Beth Israel Deaconess Medical Center · R01 · FY2021 · CA
Project 2: Regulation of Pre-mRNA Splicing in Tumorigenesis
$648,714Adrian R Krainer · Cold Spring Harbor Laboratory · P01 · FY2019 · CA
Single Cell Analysis of the Infiltrative Margins of Glioblastoma and Post Treatment Recurrence
$648,602Jeffrey N Bruce · Columbia University Health Sciences · R01 · FY2025 · NS
Targeting T cell dysfunction in glioblastoma: A proof-of-concept Phase 0/I trial of anti-TIGIT antibody AB154 in combination with anti-PD1 antibody AB122
$648,555David A. Hafler · Yale University · R01 · FY2024 · CA
Defining the role of cytomegalovirus in glioblastoma therapies
$648,427Sean Edward Lawler · Brown University · R01 · FY2023 · CA
Nanotherapeutic enhancement of interstitial thermal therapy for glioblastoma
$648,421Graeme F Woodworth · University Of Maryland Baltimore · R01 · FY2023 · CA
Understanding the cellular and functional changes in the immune tumor microenvironment of glioblastoma during progression and treatments.
$648,380Alain Charest · Beth Israel Deaconess Medical Center · R01 · FY2025 · CA
Quantitative MR-PET for Therapy Assessment in Glioma Patients
$648,246Alma Gregory Sorensen · Massachusetts General Hospital · R01 · FY2009 · CA
IMAGING TELOMERE MAINTENANCE MECHANISMS IN GLIOMAS
$648,075Pavithra Viswanath · University Of California, San Francisco · R01 · FY2021 · CA
Quantitative Image Informatics for Cancer Research (QIICR)
$647,864Ron Kikinis · Brigham And Women'S Hospital · U24 · FY2014 · CA
Imaging-based tumor forecasting to predict brain tumor progression and response to therapy
$647,029Christopher Chad Quarles · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA